404 related articles for article (PubMed ID: 16289433)
1. Transepithelial and endothelial transport of poly (amidoamine) dendrimers.
Kitchens KM; El-Sayed ME; Ghandehari H
Adv Drug Deliv Rev; 2005 Dec; 57(15):2163-76. PubMed ID: 16289433
[TBL] [Abstract][Full Text] [Related]
2. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers.
El-Sayed M; Ginski M; Rhodes C; Ghandehari H
J Control Release; 2002 Jun; 81(3):355-65. PubMed ID: 12044574
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers.
Lin YL; Khanafer K; El-Sayed ME
Nanoscale; 2010 May; 2(5):755-62. PubMed ID: 20648321
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
[TBL] [Abstract][Full Text] [Related]
5. Transport of surface engineered polyamidoamine (PAMAM) dendrimers across IPEC-J2 cell monolayers.
Pisal DS; Yellepeddi VK; Kumar A; Palakurthi S
Drug Deliv; 2008 Nov; 15(8):515-22. PubMed ID: 18720134
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
7. Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.
Pisal DS; Yellepeddi VK; Kumar A; Kaushik RS; Hildreth MB; Guan X; Palakurthi S
Int J Pharm; 2008 Feb; 350(1-2):113-21. PubMed ID: 17913410
[TBL] [Abstract][Full Text] [Related]
8. Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability.
Kolhatkar RB; Kitchens KM; Swaan PW; Ghandehari H
Bioconjug Chem; 2007; 18(6):2054-60. PubMed ID: 17960872
[TBL] [Abstract][Full Text] [Related]
9. Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: Influence of size, charge and fluorescent labeling.
Kitchens KM; Kolhatkar RB; Swaan PW; Eddington ND; Ghandehari H
Pharm Res; 2006 Dec; 23(12):2818-26. PubMed ID: 17094034
[TBL] [Abstract][Full Text] [Related]
10. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared spectroscopic study on guest-host interactions among G0-G7 amine-terminated poly(amidoamine) dendrimers and porous silica materials for simultaneously determining the molecular weight and particle diameter by multivariate calibration techniques.
Heigl N; Bachmann S; Petter CH; Marchetti-Deschmann M; Allmaier G; Bonn GK; Huck CW
Anal Chem; 2009 Jul; 81(14):5655-62. PubMed ID: 19601650
[TBL] [Abstract][Full Text] [Related]
12. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells.
Kitchens KM; Kolhatkar RB; Swaan PW; Ghandehari H
Mol Pharm; 2008; 5(2):364-9. PubMed ID: 18173246
[TBL] [Abstract][Full Text] [Related]
13. Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue.
Hubbard D; Enda M; Bond T; Moghaddam SP; Conarton J; Scaife C; Volckmann E; Ghandehari H
Mol Pharm; 2015 Nov; 12(11):4099-107. PubMed ID: 26414679
[TBL] [Abstract][Full Text] [Related]
14. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
Cheng Y; Li M; Xu T
Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
[TBL] [Abstract][Full Text] [Related]
15. Dendrimers as versatile platform in drug delivery applications.
Svenson S
Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
[TBL] [Abstract][Full Text] [Related]
16. Poly(amido amine) dendrimers in oral delivery.
Yellepeddi VK; Ghandehari H
Tissue Barriers; 2016; 4(2):e1173773. PubMed ID: 27358755
[TBL] [Abstract][Full Text] [Related]
17. Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium.
El-Sayed M; Kiani MF; Naimark MD; Hikal AH; Ghandehari H
Pharm Res; 2001 Jan; 18(1):23-8. PubMed ID: 11336349
[TBL] [Abstract][Full Text] [Related]
18. Transport of dendrimer nanocarriers through epithelial cells via the transcellular route.
Jevprasesphant R; Penny J; Attwood D; D'Emanuele A
J Control Release; 2004 Jun; 97(2):259-67. PubMed ID: 15196753
[TBL] [Abstract][Full Text] [Related]
19. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
Yellepeddi VK; Kumar A; Palakurthi S
Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
[TBL] [Abstract][Full Text] [Related]
20. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core.
Zhang XQ; Wang XL; Huang SW; Zhuo RX; Liu ZL; Mao HQ; Leong KW
Biomacromolecules; 2005; 6(1):341-50. PubMed ID: 15638538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
